Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer.
Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Cancer Sci. 2008 Jan; 99(1):81-6.
View in:
PubMed
subject areas
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Animals
Cell Growth Processes
Cell Line, Tumor
COS Cells
Dihydrotestosterone
Humans
Male
Neoplasms, Hormone-Dependent
Prostatic Neoplasms
RNA, Small Interfering
Testosterone
Transfection
authors with profiles
Yusuke Nakamura